| Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq I Tirosh, B Izar, SM Prakadan, MH Wadsworth, D Treacy, JJ Trombetta, ... Science 352 (6282), 189-196, 2016 | 3815 | 2016 |
| A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ... Cell 175 (4), 984-997. e24, 2018 | 1009 | 2018 |
| Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes JR Lin, B Izar, S Mei, S Wang, P Shah, PK Sorger elife, 2018 | 514 | 2018 |
| Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ... Cancer discovery 8 (2), 196-215, 2018 | 433 | 2018 |
| A single-cell landscape of high-grade serous ovarian cancer B Izar, I Tirosh, EH Stover, I Wakiro, MS Cuoco, I Alter, C Rodman, ... Nature medicine 26 (8), 1271-1279, 2020 | 302 | 2020 |
| Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state M Fallahi‐Sichani, V Becker, B Izar, GJ Baker, JR Lin, SA Boswell, P Shah, ... Molecular systems biology 13 (1), 905, 2017 | 238 | 2017 |
| Transcriptional mediators of treatment resistance in lethal prostate cancer MX He, MS Cuoco, J Crowdis, A Bosma-Moody, Z Zhang, K Bi, A Kanodia, ... Nature medicine 27 (3), 426-433, 2021 | 112 | 2021 |
| Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization M Trivedi, M Talekar, P Shah, Q Ouyang, M Amiji Oncogenesis 5 (8), e250-e250, 2016 | 77 | 2016 |
| Combination wt-p53 and MicroRNA-125b transfection in a genetically engineered lung cancer model using dual CD44/EGFR-targeting nanoparticles M Talekar, M Trivedi, P Shah, Q Ouyang, A Oka, S Gandham, MM Amiji Molecular Therapy 24 (4), 759-769, 2016 | 56 | 2016 |
| Bidirectional cross talk between patient‐derived melanoma and cancer‐associated fibroblasts promotes invasion and proliferation B Izar, CE Joyce, S Goff, NL Cho, PM Shah, G Sharma, J Li, N Ibrahim, ... Pigment cell & melanoma research 29 (6), 656-668, 2016 | 39 | 2016 |
| MicroRNA-34a encapsulated in hyaluronic acid nanoparticles induces epigenetic changes with altered mitochondrial bioenergetics and apoptosis in non-small-cell lung cancer cells M Trivedi, A Singh, M Talekar, G Pawar, P Shah, M Amiji Scientific Reports 7 (1), 3636, 2017 | 32 | 2017 |
| Long-chain acyl-CoA synthetase 1 role in sepsis and immunity: perspectives from a parallel review of public transcriptome datasets and of the literature J Roelands, M Garand, E Hinchcliff, Y Ma, P Shah, M Toufiq, M Alfaki, ... Frontiers in immunology 10, 2410, 2019 | 31 | 2019 |
| The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity P Ho, JC Melms, M Rogava, CJ Frangieh, J Poźniak, SB Shah, Z Walsh, ... Cancer Cell 41 (7), 1207-1221. e12, 2023 | 16 | 2023 |
| Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes P Shah, MA Forget, ML Frank, P Jiang, D Sakellariou-Thompson, ... Journal for immunotherapy of cancer 10 (2), 2022 | 10 | 2022 |
| Widespread expression of GDNF throughout rat brain after intranasal delivery of hGDNF plasmid nanoparticles AEE Aly, BT Harmon, P Shah, O Sesenoglu-Laird, L Padegimas, ... CELL TRANSPLANTATION 24 (4), 752-753, 2015 | 3* | 2015 |
| A cancer cell program promotes T-cell exclusion and resistance to checkpoint blockade. P Shah, M Cuoco, MJ Su, J Melms, R Leeson, A Kanodia, S Mei, JR Lin, ... CANCER RESEARCH 80 (19), 43-43, 2020 | 2 | 2020 |
| Single-cell RNA-sequencing and-imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade. B Izar, L Jerby-Arnon, A Rotem, P Shah, D Liu, G Zhang, B Schilling, ... Journal of Clinical Oncology 36 (15_suppl), 3074-3074, 2018 | 2 | 2018 |
| Abstract AP19: single–cell rna–sequencing of patient–derived ovarian cancer cells and patient–derived xenograft models B Izar, E Stover, I Tirosh, A Rotem, P Shah, C Rodman, S Prakadan, ... Clinical Cancer Research 23 (11_Supplement), AP19-AP19, 2017 | 2 | 2017 |
| Dissecting treatment resistance in patients with ovarian cancer and PDX-models using single-cell RNA-sequencing B Izar, I Tirosh, E Stover, A Rotem, P Shah, M Cuoco, C Rodman, J Liu, ... Cancer Research 77 (13_Supplement), 3037-3037, 2017 | 1 | 2017 |
| Abstract CT137: Efficacy and immunological outcomes of non-fucosylated anti-CTLA-4 (BMS-986218)+ degarelix acetate vs. degarelix acetate alone in men with high-risk localized … PJ McCann, CR Ager, AZ Obradovic, MG Chaimowitz, S Pan, CJ Laplaca, ... Cancer Research 84 (7_Supplement), CT137-CT137, 2024 | | 2024 |
